|
Supporting Early Psychosis Research and Implementation
|
Research Initiative
|
OS
|
NIMH
|
The Assistant Secretary of Health and Human Services for Planning and Evaluation and National Institute of Mental Health share a common interest in supporting research on the delivery of evidence-based early psychosis care, including facilitating the implementation of evidence-based coordinated specialty care for early psychosis (CSC). The agencies meet on a regular basis to inform each other''s research agenda on early psychosis care generally and CSC specifically, identify synergies in our research initiatives and formulate new research initiatives, and share related draft reports and funding opportunity announcements for comment.
|
|
Supporting the Whole Student: Mental Health and Well-Being in STEMM Undergraduate and Graduate Education
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA
|
NIMH, NIAAA, NIDA
|
The Committee, convened by the National Academy of Sciences, will conduct a study of the ways in which colleges and universities provide treatment and support for the mental health and well-being of undergraduate and graduate students, with a focus on students enrolled in science, technology, engineering, mathematics, and medicine (STEMM) courses. The committee will review present data and findings, confer with experts in the mental health field, and gain an understanding of the present resources, programs, policies, and practices geared to improving mental health in colleges and universities. With such a foundation, the Committee plans to analyze, investigate, and examine areas of improvement. The Committee aims to publish a report by the end of 2020, detailing their findings and recommendations for improving resources, programs, policies, and practices.
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
Resource Development
|
CDC
|
NCI
|
The Surveillance, Epidemiology, and End Results (SEER) program is the premier source for cancer statistics in the US. It collects information on incidence, prevalence, and survival from specific geographic areas representing 26 percent of the US population. Through SEER, the National Cancer Institute (NCI) develops reports on all of these information areas plus cancer mortality for the entire country. The site is intended for anyone interested in US cancer statistics or cancer surveillance methods.
|
|
Synthetic DNA Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
OD/OSP
|
Re-examining and updating (if necessary) the Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA, which was released in 2010.
|
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NLM
|
This activity provides support for SNOMED CT, a systematically organized computer processable collection of medical terminology covering most areas of clinical information such as diseases, findings, procedures, microorganisms, pharmaceuticals, etc. It allows a consistent way to index, store, retrieve, and aggregate clinical data across specialties and sites of care. It also helps to organize the content of medical records, reducing the variability in the way data is captured, encoded and used for clinical care of patients and research.
|
|
Task Force for Combating Antibiotic-Resistant Bacteria (CARB)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA
|
NIAID
|
Established by Executive Order 13676, the Task Force facilitates implementation of the CARB Action Plan and provides progress reports and quarterly updates describing key achievements. The Task Force is an internal government committee comprised of federal representatives and co-chaired by the Secretaries of Defense, Agriculture, and HHS.
|
|
Task Force on Research Specific to Pregnant Women and Lactating Women
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, SAMHSA
|
NCATS, NHLBI, NIAID, NICHD, NIDDK, NIMH, OD/DPCPSI/ORWH
|
The 21st Century Cures Act established PRGLAC to advise the Secretary of Health and Human Services (HHS) regarding gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women. PRGLAC was tasked with identifying these gaps and reporting its findings back to the Secretary.
|
|
Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS
|
NICHD, NCATS, NCCIH, NHLBI, NIAID, NIDDK, NIMH, OD/DPCPSI/ORWH
|
The 21st Century Cures Act established PRGLAC to advise the Secretary of Health and Human Services (HHS) regarding gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women. PRGLAC is tasked with identifying these gaps and will report its findings back to the Secretary. In addition to providing advice and guidance to the Secretary, the Task Force will prepare and submit to the Secretary and Congress a report that includes each of the following:
a plan to identify and address gaps in knowledge and research regarding safe and effective therapies for pregnant women and lactating women, including the development of such therapies; ethical issues surrounding the inclusion of pregnant women and lactating women in clinical research; effective communication strategies with healthcare providers and the public on information relevant to pregnant women and lactating women; and recommendations to improve the development of safe and effective therapies for pregnant women and lactating women. The report will also include identification of Federal activities, including the state of research on pregnancy and lactation; recommendations for the coordination of, and collaboration on research related to pregnant women and lactating women; dissemination of research findings and information relevant to pregnant women and lactating women to providers and the public; and existing Federal efforts and programs to improve the scientific understanding of the health impacts on pregnant women, lactating women, and related birth and pediatric outcomes, including with respect to pharmacokinetics, pharmacodynamics, and toxicities.
|
|
Technical and Clinical Consultation to Indian Health Service in Kidney Disease
|
Other
|
IHS
|
NIDDK
|
A National Institute of Diabetes and Digestive and Kidney Diseases senior staff member serves as Chief Clinical Consultant for Nephrology for the Indian Health Service.
|
|
Technical Consultation on Viral Hepatitis (HCV) Infection in Young Injection Drug Users
|
Meeting/ Workshop
|
CDC, OS, SAMHSA
|
NIDA, NIAID, NIDDK
|
This collaboration brings Federal and non-Federal clinician/researchers from academia, state public health departments, and communities together to present and discuss current research and other information on an emerging epidemic of viral hepatitis (HCV) infection in the 15-30 year group of Injection Drug Users (IDUs).
|